glp 1 agonists and sglt2 inhibitors GLP-1 Receptor Agonist Therapy With Without in Patients With Type 2 Diabetes Common systemic effects of either

Cyanidin-3-o-glucoside (C3G) inhibits vascular leakage regulated by microglial activation in early diabetic retinopathy and neovascularization in advanced diabetic retinopathy

Link, S

Caffeine as a factor influencing the functioning of the human body Friend or foe

That's a downside, but not a big one

For example, glutathione levels in centenarians are similar to the levels of young adults

If you want to assess your own metabolic baseline before any protocol, the key markers are: fasting insulin and fasting glucose (calculate HOMA-IR: glucose multiplied by insulin divided by 405, target below 2), high-sensitivity CRP (below 1), ferritin (50 to 100), free T3, and the triglyceride-to-HDL ratio (below 2)